Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

ACTONEL ONCE-A-WEEK TABLET 35 MG [SIN12284P]

Active ingredients: RISEDRONATE SODIUM

View product's general information
Last updated on 9 October 2026

Product Info

ACTONEL ONCE-A-WEEK TABLET 35 MG

[SIN12284P]

Product information

Active Ingredient and Strength

RISEDRONATE SODIUM - 35 MG

Dosage Form

TABLET, FILM COATED

Manufacturer and Country

BALKANPHARMA-DUPNITSA AD - BULGARIA

Registration Number

SIN12284P

Licence Holder

ZUELLIG PHARMA PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

M05BA07

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

INDICATIONS

  • Treatment of postmenopausal osteoporosis, to reduce the risk of vertebral fractures. Treatment of established postmenopausal osteoporosis, to reduce the risk of hip fractures.

  • Prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis.

  • To maintain or increase bone mass in postmenopausal women undergoing long-term (more than 3 months), systemic corticosteroid treatment at doses > 7.5mg/day prednisone or equivalent.

  • Treatment to increase bone mass in men with osteoporosis.

The optimal duration of use of bisphosphates for the treatment of osteoporosis has not been determined. All patients on bisphosphonate therapy should have the need for continued therapy re-evaluated on a periodic basis.

Dosing

DOSAGE AND ADMINISTRATION

Actonel must only be taken with plain water.

Actonel must be taken 30 minutes before the first food or drink other than water.

To facilitate delivery to the stomach, Actonel should be taken in an upright position and the patient should avoid lying down for 30 minutes.

Patients should not chew or suck on the tablet because of the potential for oropharyngeal irritation.

Osteoporosis: The recommended dose is 35mg once a week, taken on the same day each week. Patients should be instructed that if they miss a dose of ACTONEL 35mg Once-A-Week, they should take 1 tablet on the morning after they remember and return to taking 1 tablet once a week, as originally scheduled on their chosen day. Patient should not take 2 tablets on the same day.

Use in the elderly: No dose adjustment is necessary.

Renal impairment: No dose adjustment is necessary in patients with mild to moderate renal insufficiency (creatinine clearance 30 to 60 mL/minute). Actonel is not recommended in patients with severe renal impairment (creatinine clearance < 30 mL/minute) due to limited clinical data.

Children: Safety and efficacy of Actonel has not been established in patients under 18 years of age.

Men: No dose adjustment is necessary.

Compatibility with other Drugs
Calcium, antacids, aluminium and some oral medications will interfere with the absorption of Actonel and therefore should be taken at a different time of the day.

Contraindications

CONTRAINDICATIONS

  • Known hypersensitivity to the drug or any of the ingredients.

  • Hypocalcaemia (see Precautions – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information)

  • Inability to stand or sit upright for at least 30 minutes.

  • Pregnancy & lactation

  • Severe renal impairment (creatinine clearance <30ml/min)